R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2022
Back to search
Official data from USPTO
LSII
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
03/08/2022
Trademark type
Combined
Nice classes
5
Filing date
12/26/2019
Registration date
03/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2022
Last transaction
03/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
Tokyo, JP
Examiner
HENRY,NAKIA D
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a hollow sphere design in color outlined by brush-strokes, which looks like a white-colored sphere wrapped by colorful ribbons. The upper part of the sphere has a blue stroke, having a gleam and showing color gradation. The bottom part to the right side of sphere is outlined by a navy blue stroke. There is a red line that streaks across the center of the sphere from the top to the bottom. The light blue ribbon does not touch the dark blue ribbon. The space in between is void of color. Stylized and capitalized word" LSII" in gray is shown on the right side of the sphere design.
Holders and representatives
Holders
Life Science Institute, Inc.
Representatives
Danielle I. Mattessich MERCHANT & GOULD P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for treatment of hypoxic-ischemic encephalopathyepidermolysis bullosacerebral infarctionstroke apoplexia cerebriacute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of hypoxic-ischemic encephalopathyepidermolysis bullosacerebral infarctionstroke apoplexia cerebriacute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of hypoxic-ischemic encephalopathyepidermolysis bullosacerebral infarctionstroke apoplexia cerebriacute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of hypoxic-ischemic encephalopathyepidermolysis bullosacerebral infarctionstroke apoplexia cerebriacute myocardial infarction and spinal cord injuries
Publications
History of USPTO decisions and trademark events.
37 publications found
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/28/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/28/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/17/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
12/17/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/29/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/14/2021
PUBO
PUBLISHED FOR OPPOSITION
09/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2021
GNRT
NON-FINAL ACTION E-MAILED
03/22/2021
CNRT
NON-FINAL ACTION WRITTEN
03/22/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/27/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/27/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/19/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/11/2021
GNSL
LETTER OF SUSPENSION E-MAILED
01/11/2021
CNSL
SUSPENSION LETTER WRITTEN
01/11/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/19/2020
GNSL
LETTER OF SUSPENSION E-MAILED
06/19/2020
CNSL
SUSPENSION LETTER WRITTEN
06/19/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2020
ALIE
ASSIGNED TO LIE
06/17/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/24/2020
GNRT
NON-FINAL ACTION E-MAILED
03/24/2020
CNRT
NON-FINAL ACTION WRITTEN
03/24/2020
DOCK
ASSIGNED TO EXAMINER
03/20/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2020
NWAP
NEW APPLICATION ENTERED
12/30/2019
Continuous trademark protection
Get notified about every new filing that threatens LSII or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.